Aurinia Completes NDA and Requests Priority Review of Voclosoporin by FDA for Lupus Nephritis
May 28, 2020 The Lupus Research Alliance is pleased to share that Aurinia Pharmaceuticals Inc submitted a New Drug...
Read MoreHome
What can the world learn from lupus amidst this COVID-19 reality and beyond?
Why us?
Our funding is leading to key discoveries that are improving diagnosis and therapies, while enabling researchers to find the way toward prevention and ultimately a cure for lupus.
100%
of funds
go to support
research programs
500
Grants
fostering scientific
breakthroughs
$200
million
in support of
cutting-edge research
Recent Lupus Research Breakthroughs
News and Events
COVID-19 Caused Hydroxychloroquine Issues for Third of Lupus Patients, New LRA Survey Finds
NEW YORK, NY, May 28. More than one third of people with lupus experienced significant issues filling their hydroxychloroquine...
Read MoreLupus and COVID-19: What You Need to Know – LIVE WEBCAST May 21 at 6 PM ET
Since the arrival of the novel coronavirus, lupus and the most prescribed drug used to treat it – hydroxychloroquine...
Read More
We’re building a strong and vibrant community for people living with lupus and their friends and family. Join us!
Watch these lupus warrior's stories
